Clinical trial Recruiting at 1 site Observational Ages 50 to 65 Women only

Does hip orientation and leg alignment relate to stress incontinence in postmenopausal women

Official title: Perineal Ultrasound α/β Angles, Post-Void Residual Volume, and Lower-Limb Alignment in Symptomatic and Asymptomatic Postmenopausal Women With Stress Incontinence.

Run by Benha University · NCT07747727 · Data updated 2026-11-12

This study tests whether hip angles, post-void urine volume, and leg/spine alignment differ between postmenopausal women with and without stress urinary incontinence.

Quick facts

Study typeObservational
Ages50 Years to 65 Years
SexWomen only
Enrollment120 (estimated)
SponsorBenha University
Academic / other
Locations1 site (Banhā, Qalyoubia)
StatusRecruiting
StartedFebruary 3, 2026
Main results expectedAugust 2, 2026
Study endsAugust 15, 2026
Registry record updatedAugust 5, 2026
Trial IDNCT07747727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Postmenopausal women (≥50) who can stand and walk independently and have either symptomatic stress incontinence or no leakage with minimal symptoms.

Probably not a fit

Women with urge or mixed incontinence as the dominant symptom or those with significant pelvic organ prolapse or major hip/spine surgeries may not benefit from the specific comparisons planned.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, case-control analysis compares imaging and alignment measures in symptomatic versus asymptomatic postmenopausal women. It uses transperineal ultrasound to measure hip α/β angles at rest and during Valsalva, assesses post-void residual urine, and evaluates spinopelvic and lower-limb alignment. The study analyzes cross-sectional data from anonymized datasets at a Saudi urogynecology clinic, with statistical tests and corrections for multiple comparisons, and also explores correlations between residual urine and alignment variables within each group. Inclusion requires at least 12 months of amenorrhea and independent standing/walking; exclusions include dominant urge/mrequency symptoms, prior pelvic floor surgery, severe prolapse, neurological bladder issues, and certain hip/spine surgeries.

Why it matters

Potential benefit: If successful, findings could broaden understanding of factors contributing to stress incontinence and inform more comprehensive assessment approaches.

How similar studies have gone: Previous research has shown that biomechanical and imaging markers can relate to continence mechanisms, though the integration of spinopelvic and lower-limb measures with PVR in SUI is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: post menoupausal women, who had at least 12 months of amenorrhea or follicle-stimulating hormone values within the menopausal range and who could stand and walk independently to allow lower-limb and alignment assessments.

\-

Exclusion Criteria:women with urge or mixed incontinence as the dominant symptom, prior pelvic floor or anti-incontinence surgery, severe pelvic organ prolapse (stage 3 or greater), or neurological conditions affecting bladder function or gait, as well as those with hip or spine surgery likely to alter spinopelvic parameters

\-

Where it's running

  • out patient clinic, Faculty of Physical Therapy, Benha University
    Banhā, Qalyoubia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.